Mir Hashim
Chief Tech/Sci/R&D Officer bij RANI THERAPEUTICS HOLDINGS, INC.
Vermogen: 4 M $ op 31-03-2024
Profiel
Mir Hashim is currently the Chief Scientific Officer & Director at Rani Therapeutics LLC.
He is also the Vice President-Research & Development at InCube Labs LLC since 2008.
Additionally, Dr. Hashim holds the position of Chief Scientific Officer at Rani Therapeutics Holdings, Inc. since 2021.
Previously, he worked as the Head-Pharmacology at GSK Plc.
Dr. Hashim holds a doctorate degree from Memorial University of Newfoundland, an undergraduate degree from Osmania University, and a graduate degree from the University of Hyderabad.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
Rani Therapeutics LLC
 Rani Therapeutics LLC Pharmaceuticals: MajorHealth Technology Rani Therapeutics LLC develops a oral biotherapeutics technology for the oral delivery of drug molecules, including peptides, proteins, and antibodies. Its products include TNFa Inhibitors, Parathyroid Hormone, Human Growth Hormone, Somatostatin, and Basal Insulin. The company is headquartered in San Jose, CA. 2.55% | 29-07-2021 | 786 392 ( 2.55% ) | 2 M $ | 31-03-2024 |
| 31-03-2024 | 374 119 ( inf% ) | 1 M $ | 31-03-2024 | |
| 31-03-2024 | 148 415 ( 0.57% ) | 461 571 $ | 31-03-2024 | |
| 31-03-2024 | 25 649 ( 0.09% ) | 79 768 $ | 31-03-2024 |
Actieve functies van Mir Hashim
| Bedrijven | Functie | Begin |
|---|---|---|
| RANI THERAPEUTICS HOLDINGS, INC. | Chief Tech/Sci/R&D Officer | 06-04-2021 |
Rani Therapeutics LLC
Rani Therapeutics LLC Pharmaceuticals: MajorHealth Technology Rani Therapeutics LLC develops a oral biotherapeutics technology for the oral delivery of drug molecules, including peptides, proteins, and antibodies. Its products include TNFa Inhibitors, Parathyroid Hormone, Human Growth Hormone, Somatostatin, and Basal Insulin. The company is headquartered in San Jose, CA. | Chief Tech/Sci/R&D Officer | - |
InCube Labs LLC
 InCube Labs LLC Medical SpecialtiesHealth Technology InCube Labs LLC provides therapeutic services and medical devices. It offers treatment to central nervous system, cardiovascular disease, metabolic diseases, micronutrient deficiency, and gastrointestinal end-stage renal disease cancer. The company was founded on February 22, 2007 and is headquartered in San Jose, CA. | Chief Tech/Sci/R&D Officer | 01-09-2008 |
Eerdere bekende functies van Mir Hashim
| Bedrijven | Functie | Einde |
|---|---|---|
| GSK PLC | Corporate Officer/Principal | - |
Opleiding van Mir Hashim
| Memorial University of Newfoundland | Doctorate Degree |
| Osmania University | Undergraduate Degree |
| University of Hyderabad | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| GSK PLC | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Rani Therapeutics LLC
Rani Therapeutics LLC Pharmaceuticals: MajorHealth Technology Rani Therapeutics LLC develops a oral biotherapeutics technology for the oral delivery of drug molecules, including peptides, proteins, and antibodies. Its products include TNFa Inhibitors, Parathyroid Hormone, Human Growth Hormone, Somatostatin, and Basal Insulin. The company is headquartered in San Jose, CA. | Health Technology |
| Rani Therapeutics Holdings, Inc. | |
InCube Labs LLC
InCube Labs LLC Medical SpecialtiesHealth Technology InCube Labs LLC provides therapeutic services and medical devices. It offers treatment to central nervous system, cardiovascular disease, metabolic diseases, micronutrient deficiency, and gastrointestinal end-stage renal disease cancer. The company was founded on February 22, 2007 and is headquartered in San Jose, CA. | Health Technology |
